Basilar artery thrombosis in a child heterozygous for prothrombin gene G20210A mutation

Journal of Child Neurology

Volumn 22, Issue 3, 2007, Pages 329-331

  Hüdaoǧlu, Orkide ^a   Kurul, Semra ^a   Yiş, Uluç ^a   Dirik, Eray ^a   Çakmakçi, Handan ^a   Men, Süleyman ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Arterial ischemic stroke; Child protrombin G20210A; Mutation

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PROTHROMBIN;

ANTICOAGULANT THERAPY; ARTICLE; BASILAR ARTERY; BLOOD EXAMINATION; BRAIN ANGIOGRAPHY; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; DIGITAL SUBTRACTION ANGIOGRAPHY; GENETIC RISK; HEMIPARESIS; HETEROZYGOSITY; HUMAN; IMAGE ANALYSIS; MALE; MUTATIONAL ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REHABILITATION CARE; SCHOOL CHILD;

BASILAR ARTERY; CHILD; HETEROZYGOTE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MUTATION; PROTHROMBIN;

EID: 34249847101     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807299861     Document Type: Article

References (12)

1. de Veber G. Arterial ischemic strokes in infants and children: An overview of current approaches. Semin Thromb Hemost. 2003; 29: 567-573.
2. Andrew M., David M., de Veber G., Brooker LA Arterial thromboembolic complications in paediatric patients. Thromb Haemost. 1997; 78: 715-725.
3. Poort SR, Rosendall FR, Reitsma PH, Bertina RM A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698-3703.
4. Garcia Gomez EB, van Goor Mpj, Leebeek Fwg, Brouwers GJ, Koudstaal PJ, Dippel Dwj. Elevated prothrombin is a risk factor for cerebral arterial ischemia in young adults. Clin Neuro Neurosurg. 2002; 104: 285-288.
5. Bonduel M., Sciuccati G., Hepner M., et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003; 73: 81-86.
6. De Stefano V, Chiusolo P., Paciaroni K., et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998; 91: 3562-3565.
7. Lalouschek W., Schillinger M., Hsieh K. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke. 2005; 36: 1405-1409.
8. Zenz W., Bodo Z., Plotho J., et al. Factor V Leiden and prothrombin G20210A variant in children with ischemic stroke. Thromb Haemost. 1998; 80: 763-766.
9. Kenet G., Sadetzki S., Murad H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31: 1283-1288.
10. McColl MD, Chalmers CA, Thomas A., et al. Factor V Leiden, prothrombin G20210A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999; 81: 690-694.
11. Young G., Manco-Johnson M., Gill JC, et al. Clinical manifestations of the prothrombin G20210A mutation in children: A pediatric coagulation consortium study. J Thromb Haemost. 2003; 1: 958-962.
12. Gurgey A., Unal S., Okur H., Duru F., Gumruk F. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. Pediatr Hematol Oncol. 2005; 22: 309-314.